|
Kanestri V.G., Kravchenko A.V., Gankina N.Yu.
Hepatotoxicity of antiretroviral therapy in HIV-infected patients
|
№1 / 2015
|
|
Pokrovskaya A.V., Ladnaya N.N., Yurin O.G., Dementieva L.A., Pokrovsky V.V.
A cascade model in the evaluation of the efficiency of healthcare for HIV-positive people
|
№1 / 2015
|
|
Kozyrina N.V., Ladnaya N.N., Sokolova E.V., Tushina O.I., Narsia R.S., Pronina S.I., Pokrovsky V.V.
Mother-to-child HIV transmission during breastfeeding
|
№1 / 2015
|
|
Moskvicheva M.G., Radzikhovskaya M.V.
Analysis of the causes of death in HIV-infected persons in the Chelyabinsk Region
|
№6 / 2014
|
|
Yurin O.G., Kravchenko A.V., Kanestri V.G., Pokrovskaya A.V., Shakhgildyan V.I., Volkova S.B.
Dual antiretroviral therapy with lopinavir and ritonavir
|
№6 / 2014
|
|
Chernyavskaya O.A., Ioannidi E.A., Ogulchanskaya E.G.
A comparative analysis of changes in HIV/AIDS awareness among young people living in the Volgograd Region over the past decade
|
№6 / 2014
|
|
Sarmometov E.V., Sergevnin V.I., Shmagin D.V., Mikova O.E.
Primary HIV infection in the development of HIV/tuberculosis co-infection
|
№5 / 2014
|
|
Kozyrina N.V., Narsia R.S., Yurin O.G.
Abacavir and lamivudine as a nucleoside base of antiretroviral therapy
|
№5 / 2014
|
|
Moskvicheva M.G., Radzikhovskaya M.V., Kuzyukin N.N.
The specific features of HIV infection epidemic in the Chelyabinsk Region
|
№5 / 2014
|
|
Moskvicheva M.G., Radzikhovskaya M.V.
Experience with the HIV protease inhibitor fosamprenavir in first-line antiretroviral therapy regimens in the Chelyabinsk Region
|
№3 / 2014
|
|
Semenova N.Yu., Chebotareva T.V., Bogdanova L.I., Demidov V.I.
The clinical and morphological features of HIV-associated tuberculosis
|
№3 / 2014
|
|
Kanestri V.G.
Contribution of a fixed-dose abacavir/lamivudine combination to improving treatment compliance in HIV-infected patients
|
№6 / 2013
|
Русский
